PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

RNA regulator of melanoma could be a new target for cancer therapy

2012-05-11
(Press-News.org) May 11, 2012 – Melanoma is the most deadly form of skin cancer, estimated by the National Cancer Institute to afflict more than 70,000 people in the United States annually and the incidence rate continues to rise. In a study published online in Genome Research (www.genome.org), researchers have identified a previously unknown non-coding RNA that plays an important role in the biology of melanoma, a finding that could lead to a new target for therapy.

Most skin cancers are nonmelanomas, arising from cells other than melanocytes (the melanin-producing cells that are responsible for a suntan). Melanomas, skin cancers that arise from melanocytes, are less common but more dangerous because they can migrate deep into the skin to find blood and lymphatic vessels that help the tumor cells to grow and spread to other parts of the body.

Oncogenes are genes that have the potential to cause cancer, and are often mutated in tumor cells, including melanomas. Mutations in the oncogene BRAF are present in more than 70% of melanomas, and the vast majority of BRAF mutants are a single mutant form, BRAFV600E. Inhibitors of BRAFV600E used in the clinic can induce tumor regression, but patients eventually relapse.

In order to better understand the biology of oncogenic BRAF and identify new targets for therapy, researchers are investigating the RNA world of cancer. RNAs are the messenger molecules that the cell primarily uses to transmit the information stored in the DNA sequence, and translate it into functional proteins. However, about 50% of transcribed RNAs actually code for no proteins at all, but many RNAs may still have critical regulatory roles to play.

In this report, a team of researchers led by Drs. Ross Flockhart and Paul Khavari of the Stanford University School of Medicine has delved into the RNA world of BRAFV600E melanomas by sequencing and analyzing the RNA "transcriptome" of patient samples. They looked for RNA transcripts, including those that may never have been characterized before, that are rewired by BRAFV600E and may be relevant to melanoma.

"By digging deeper than ever before, we found more than 100 genes encoding long non-coding RNAs that are dramatically altered by BRAFV600E," said Flockhart. Long non-coding RNAs (lncRNAs) are garnering significant interest, as these molecules have been implicated in diverse cellular functions, but the role of lncRNAs in cancer is not well understood. Of the lncRNAs altered by BRAFV600E, Flockhart and colleagues homed in on a previously uncharacterized lncRNA gene that is recurrently and highly induced in melanomas, called BANCR. "Increased activation of the novel gene we discovered does not seem to be an isolated event," Flockhart noted. "It will be interesting to investigate if this is also the case in other cancers."

To test what role BANCR might be playing in melanoma, the team found that by turning off BANCR in the cancer cell by a technique called knockdown, the ability of the melanoma cells to migrate in a cell culture experiment was impaired. This indicates that BANCR is required for full migratory capacity in melanoma, and could be a potential target for therapy.

The authors explained that their work illustrates the power of RNA sequencing to study a cancer such as melanoma and identify a previously unknown regulator of disease progression. As studies such as this paint a more complete picture of cancer biology, we will have a better understanding of how tumors evade drugs, and how previously unknown players such as BANCR could be new targets for treatment.

### Scientists from the Veterans Affairs Palo Alto Healthcare System (Palo Alto, CA) and Stanford University (Stanford, CA) contributed to this study.

This work was supported by the United States Veterans Affairs Office of Research and Development and by the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Media contacts: The authors are available for more information by contacting Krista Conger, Ph.D. in the Office of Communication & Public Affairs at the Stanford University School of Medicine (+1-650-725-5371; kristac@stanford.edu).

Interested reporters may obtain copies of the manuscript via email from Peggy Calicchia, Administrative Assistant, Genome Research (calicchi@cshl.edu, +1-516-422-4012).

About the article: The manuscript will be published online ahead of print on Friday, May 11, 2012. Its full citation is as follows: Flockhart RJ, Webster DE, Qu K, Mascarenhas N, Kovalski J, Kretz M, Khavari PA. BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Res doi: 10.1101/gr.140061.112.

About Genome Research:

Launched in 1995, Genome Research (www.genome.org) is an international, continuously published, peer-reviewed journal that focuses on research that provides novel insights into the genome biology of all organisms, including advances in genomic medicine. Among the topics considered by the journal are genome structure and function, comparative genomics, molecular evolution, genome-scale quantitative and population genetics, proteomics, epigenomics, and systems biology. The journal also features exciting gene discoveries and reports of cutting-edge computational biology and high-throughput methodologies.

About Cold Spring Harbor Laboratory Press:

Cold Spring Harbor Laboratory is a private, nonprofit institution in New York that conducts research in cancer and other life sciences and has a variety of educational programs. Its Press, originating in 1933, is the largest of the Laboratory's five education divisions and is a publisher of books, journals, and electronic media for scientists, students, and the general public.

Genome Research issues press releases to highlight significant research studies that are published in the journal.


ELSE PRESS RELEASES FROM THIS DATE:

Citizens Property Insurance Corporation Prepares for Trial Against Corless Associates and the Wells Law Group

2012-05-11
On June 11, 2012, Citizens is set to try the case of Gulf View Village Condo Association v. Citizens Property Insurance Corporation, pending in Pasco County, Florida. The case relates to a 2009 claim for damages due to settlement at a property occupied primarily by retirees and their families. This case illustrates the lengths Citizens believes it can go to delay and stall paying on its legal obligations. Although Citizens was told as early as November 2009 that there was sinkhole activity at the property in one building and as early as August 2010 in its other 4, Citizens ...

Hubble observes a dwarf galaxy with a bright nebula

Hubble observes a dwarf galaxy with a bright nebula
2012-05-11
The starry mist streaking across this image obtained by the NASA/ESA Hubble Space Telescope is the central part of the dwarf galaxy known as NGC 2366. The most obvious feature in this galaxy is a large nebula visible in the upper-right part of the image, an object listed just a few entries prior in the New General Catalogue as NGC 2363. A nearby yellowish swirl is not in fact part of the nebula. It is a spiral galaxy much further away, whose light is shining right through NGC 2366. This is possible because galaxies are not solid objects. While we see the stars because ...

Study Shows the Benefits of Speed Limiters for Commercial Drivers

2012-05-11
Six years ago, the American Trucking Associations (ATA) advised the Federal Motor Carrier Safety Administration (FMCSA) and the National Highway Traffic Safety Administration (NHTSA) that using speed limiters --electronic devices that limit the top speed of commercial vehicles -- would help prevent commercial trucking accidents and make roads safer for motorists. Now, according to ATA CEO Bill Graves, a recent study published by the FMCSA proves that these devices are an answer to saving lives of many commercial truck drivers. "This study confirms what ATA has been ...

Speed Limits Matter When Trying to Prevent Serious Accidents

2012-05-11
National measures to curb speeding on local roads and interstate highways have proved to be largely ineffective. In fact, the federal government repealed the national speed limit in 1995, prompting some states to raise their limit as high as 85 mph. Despite all the technology to increase automobile safety and measures to make roads safer, speeding contributes to around one third of the 10,000 traffic fatalities each year, according to AutoGuide.com. A 1998 study estimated the annual economic cost associated with deaths, injuries and damage from speeding was $27.7 billion. The ...

Systemic sclerosis complications more severe in African Americans than Caucasians

2012-05-11
African Americans have more severe complications from systemic sclerosis, also known as scleroderma, than Caucasians. Findings published today in, Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), show that compared with Caucasians, African-American patients were more likely to have antibodies that increased frequency and severity of pulmonary fibrosis, which is associated with decreased survival. According to the ACR there are 49,000 adult American diagnosed with systemic sclerosis—an autoimmune disease where collagen build-ups in the ...

Unseen planet revealed by its gravity

Unseen planet revealed by its gravity
2012-05-11
More than a 150 years ago, before Neptune was ever sighted in the night sky, French mathematician Urbain Le Verrier predicted the planet's existence based on small deviations in the motion of Uranus. In a paper published today in the journal Science online, a group of researchers led by Dr. David Nesvorny of Southwest Research Institute has inferred another unseen planet, this time orbiting a distant star, marking the first success of this technique outside the solar system. Using a laborious computational method to assess the effects of gravity, known as gravitational ...

Breathalyzers in Colorado

2012-05-11
Everyone has heard about them. Whether one has seen them on television or in driver's education classes, every driver is aware that police officers use an Intoxilyzer or other breath test device as a tool to determine if a driver is operating a vehicle while under the influence of alcohol. Yet, many drivers have questions about these devices. Are we required to submit to a Breathalyzer test? How do these devices work? How many kinds are there? Are they accurate? People may ponder these questions at one time or another, but they rarely stop to think about the answers. ...

HPV-positive throat cancer patients respond better to radiotherapy alone than HPV-negative patients

2012-05-11
Barcelona, Spain: New findings from a large Danish database of cancer patients suggest that, even though the human papilloma virus (HPV) can trigger throat cancer, patients who are HPV-positive and are light smokers, or don't smoke at all, have a good response to treatment using radiotherapy alone, without the addition of chemotherapy with its consequent toxic side-effects. Presenting her research at the 31st conference of the European Society for Radiotherapy and Oncology (ESTRO 31) [1] today [Thursday], Dr Pernille Lassen, a resident in medical and radiation oncology ...

The Police Are at Your Door. Do You Know What to Do?

2012-05-11
"Trust me; things will be a lot easier if you cooperate." These words -- or something like them -- are spoken by countless law enforcement officers every day. They're true, but only in part: things will be a lot easier for the police if you give them what they are asking for. However, if you are suspected of a crime, asserting your rights at the early stages of the investigation is the most important step you can take to protect your future. If you suspect that you may be under investigation, be polite, but don't give the police access to any information ...

3-D image guided brachytherapy helps avoid hysterectomies for cervical cancer patients

2012-05-11
Barcelona, Spain: Delivering radiotherapy directly to cancer of the cervix using 3-D imaging techniques is effective at controlling the return and spread of the disease and, in most cases, avoids the need for hysterectomies, according to research presented at the World Congress of Brachytherapy [1 & 2] today (Thursday). Dr Renaud Mazeron said that a review of the use of 3-D image guided adaptive brachytherapy (IGABT) after a course of chemotherapy and radiotherapy given together (concomitant chemoradiation) in 163 patients treated between 2004-2009 at the Institut Gustave ...

LAST 30 PRESS RELEASES:

Multi-resistance in bacteria predicted by AI model

Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

[Press-News.org] RNA regulator of melanoma could be a new target for cancer therapy